gut microbiota

New study challenges link between early-life gut microbiota and obesity risk

The findings suggest that the composition of the gut microbiota in early life is not a key factor in obesity risk.

Small study uncovers gut microbiota differences in schizophrenia

New research has now uncovered differences in the gut microbiota composition between people with the condition and those without.

The role of gut microbiota imbalance in gut-liver axis dysfunction and cancer progression

Professor Maria Rescigno explores the critical role of the gut microbiota in maintaining intestinal barrier integrity and its implications for health. 

Gut bacteria may improve response to immunotherapy in people with melanoma

Specific gut microbiota features correlate with better responses to immunotherapy in people with melanoma.

Metabolomics in alcohol dependence: uncovering biomarkers and gut-brain interactions through new technologies

Nathalie Maria Delzenne from Université Catholique de Louvain (Belgium) explains how gut microbiota and systemic inflammation impact cravings and depressive symptoms in affected individuals. 

New AI model predicts gut microbial load, revealing its role in health and disease

Including microbial load in microbiota studies can help researchers better understand how gut bacteria influence diseases, leading to more accurate diagnoses and effective treatments.

Tailored dietary strategies may boost remission for Crohn’s disease

The findings highlight the importance of maintaining a healthy microbiota after EEN and suggest that personalized dietary approaches can help induce remission for children with Crohn’s disease.

Integrating microbiome data into food safety: EFSA’s approach to risk assessment in the agri-food chain

Konstantinos Paraskevopoulos (European Food Security Autority, EFSA) underscores the importance of microbiome data in assessing the safety of food and feed products across the agri-food chain.

Study links gut bacteria to Alzheimer’s, uncovering potential new targets

The findings suggest that gut microbes and LPC are potential therapeutic targets for Alzheimer's disease.

New virus-like agents identified in human gut and oral microbiotas

Researchers have identified a new class of virus-like agents known as "obelisks" in oral and stool samples from hundred of people.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top